Literature DB >> 15063788

High level of orexin A observed in the phenylketonuria mouse brain is due to the abnormal expression of prepro-orexin.

Sankar Surendran1, Peter L Rady, Sylvia Szucs, Kimberlee Michals-Matalon, Stephen K Tyring, Reuben Matalon.   

Abstract

Orexins/hypocretins are recently discovered neuropeptides, synthesized mainly in the lateral hypothalamus of the brain. Orexins regulate various functions including sleep and apetite. We recently reported increased amount of orexin A in the phenylketonuria (PKU) mouse brain. Whether this is caused by overexpression of the precursor for orexins, prepro-orexin was studied in the PKU mouse brain. Microarray expression analysis revealed overexpression of orexin gene in the brain of PKU mouse. Quantitative real-time RT-PCR showed increased level of prepro-orexin mRNA in the PKU mouse brain. In addition, expression of genes associated with cell signal and growth regulation was also affected in the PKU mouse brain, as observed by microarray analysis. These data suggest that up-regulation of orexin mRNA expression is the possible factor for inducing high orexin A in the brain of PKU mouse. The metabolic environment in the brain of PKU mouse affects normal expression of other genes possibly to result in pathophysiology seen in the PKU mouse, if documented also in patients with PKU.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063788     DOI: 10.1016/j.bbrc.2004.03.079

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Tissue-specific activation of mitogen-activated protein kinases for expression of transthyretin by phenylalanine and its metabolite, phenylpyruvic acid.

Authors:  Joo Won Park; Mi Hee Lee; Jin Ok Choi; Hae Young Park; Sung Chul Jung
Journal:  Exp Mol Med       Date:  2010-02-28       Impact factor: 8.718

2.  Sleep Disturbances in Phenylketonuria: An Explorative Study in Men and Mice.

Authors:  Vibeke M Bruinenberg; Marijke C M Gordijn; Anita MacDonald; Francjan J van Spronsen; Eddy A Van der Zee
Journal:  Front Neurol       Date:  2017-04-26       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.